Cancer impacts millions globally, with lifestyle choices such as smoking, diet, physical activity, alcohol consumption, sun ...

By unraveling the complex choreography of cellular machinery, Michigan State University researchers are helping identify the ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Patients with low-grade upper tract urothelial carcinoma receiving primary treatment with 6 once-weekly pyelocalyceal doses ...

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR ...

Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several ...

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...

Researchers have used machine learning to predict which patients with advanced bladder cancer are most likely to respond to ...

Scientists have uncovered a promising way to fight prostate cancer by targeting a single enzyme, PI5P4Kα. This discovery ...

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.